G. Jensen

发表

Artificial protein cavities as specific ligand-binding templates: characterization of an engineered heterocyclic cation-binding site that preserves the evolved specificity of the parent protein.

D. Goodin, R. Musah, G. Jensen, 2002, Journal of molecular biology.

Site-directed mutagenesis of Azotobacter vinelandii ferredoxin I. Changes in [4Fe-4S] cluster reduction potential and reactivity.

P. Stephens, G. Jensen, F. Armstrong, 1991, The Journal of biological chemistry.

Variation in strength of an unconventional C-H to O hydrogen bond in an engineered protein cavity

D. McRee, D. Goodin, R. Musah, 1997 .

Calculation of the redox potentials of iron-sulfur proteins: the 2-/3-couple of [Fe4S*4Cys4] clusters in Peptococcus aerogenes ferredoxin, Azotobacter vinelandii ferredoxin I, and Chromatium vinosum high-potential iron protein.

A. Warshel, P. Stephens, G. Jensen, 1994, Biochemistry.

Opportunities and challenges in commercial pharmaceutical liposome applications.

G. Jensen, D. F. Hodgson, 2020, Advanced drug delivery reviews.

The role of aspartate‐235 in the binding of cations to an artificial cavity at the radical site of cytochrome c peroxidase

M. M. Fitzgerald, D. McRee, D. Goodin, 1995, Protein science : a publication of the Protein Society.

Theoretical determination of the vibrational absorption and Raman spectra of 3-methylindole and 3-methylindole radicals

S. Suhai, R. Nieminen, C. Chabalowski, 2001 .

Circular Dichroism and X-ray Spectroscopies of Azotobacter vinelandii Nitrogenase Iron Protein

M. J. Ryle, G. Jensen, W. Lanzilotta, 1996, The Journal of Biological Chemistry.

The Viscoelastic Properties of the Fungal Cell Wall Allow Traffic of AmBisome as Intact Liposome Vesicles

A. Casadevall, G. Jensen, N. Gow, 2018, mBio.

Tissue pharmacokinetics and pharmacodynamics of AmBisome® (L-AmBis) in uninfected and infected animals and their effects on dosing regimens

G. Jensen, J. Adler-Moore, R. Proffitt, 2017, Journal of liposome research.

Cunninghamella bertholletiae Infection in a Bone Marrow Transplant Patient: Amphotericin Lung Penetration, MIC Determinations, and Review of the Literature

K. Garey, G. Jensen, S. Pendland, 2001, Pharmacotherapy.

Azotobacter vinelandii ferredoxin I. Aspartate 15 facilitates proton transfer to the reduced [3Fe-4S] cluster.

P. Stephens, G. Jensen, F. Armstrong, 1993, The Journal of biological chemistry.

Circular dichroism and magnetic circular dichroism of Azotobacter vinelandii ferredoxin I.

P. Stephens, F. Devlin, G. Jensen, 1991, Biochemistry.

Pharmacokinetics and Pharmacodynamics of Amphotericin B Deoxycholate, Liposomal Amphotericin B, and Amphotericin B Lipid Complex in an In Vitro Model of Invasive Pulmonary Aspergillosis

G. Jensen, T. Walsh, J. Majithiya, 2010, Antimicrobial Agents and Chemotherapy.

Oral Presentations—Abstracts

A. Eggermont, K. Edwards, A. Chanan-Khan, 2003, Turkish Journal of Biochemistry.

Use of vibrational spectroscopy to study protein and DNA structure, hydration, and binding of biomolecules: A combined theoretical and experimental approach

K. Frimand, R. Wade, S. Suhai, 2006 .

Density Functional and MP2 Calculations of Spin Densities of Oxidized 3-Methyl Indole. Models for Tryptophan Radicals.

D. Goodin, G. Jensen, S. Bunte, 1996 .

Construction of a bisaquo heme enzyme and binding by exogenous ligands.

M. M. Fitzgerald, D E McRee, D B Goodin, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Determination of the Relative Toxicity of Amphotericin B Formulations: A Red Blood Cell Potassium Release Assay

G. Jensen, C. Weissman, N. Amirghahari, 1999 .

Comparative Efficacies, Toxicities, and Tissue Concentrations of Amphotericin B Lipid Formulations in a Murine Pulmonary Aspergillosis Model

G. Jensen, J. Adler-Moore, R. Proffitt, 2006, Antimicrobial Agents and Chemotherapy.

Comparison of the Physicochemical, Antifungal, and Toxic Properties of Two Liposomal Amphotericin B Products

G. Jensen, J. Adler-Moore, R. Proffitt, 2007, Antimicrobial Agents and Chemotherapy.

Erroneous determination of hyperphosphatemia ('pseudohyperphosphatemia') in sera of patients that have been treated with liposomal amphotericin B (AmBisome).

G. Jensen, S. Wolf, T. H. Bunch, 2010, Clinica chimica acta; international journal of clinical chemistry.

Liposomal amphotericin B—the past

G. Jensen, C. Lass‐Flörl, R. Brüggemann, 2022, The Journal of antimicrobial chemotherapy.

Process Development and Quality Control of Injectable Liposomal Therapeutics

G. Jensen, N. Hu, C. G. Eley, 2016, Liposome Technology.

The care and feeding of a commercial liposomal product: liposomal amphotericin B (AmBisome®)

G. Jensen, Gerard M Jensen, 2017, Journal of liposome research.

Toxicity and efficacy differences between liposomal amphotericin B formulations in uninfected and Aspergillus fumigatus infected mice.

G. Jensen, J. Adler-Moore, J. Olson, 2015, Medical mycology.

A liposomal dispersion formulation of propofol: formulation, pharmacokinetics, stability, and identification of an oxidative degradant

G. Jensen, S. Bunte, C. S. Ashvar, 2008 .

Conventional Liposome Performance and Evaluation: Lessons from the Development of Vescan

G. Jensen, T. H. Bunch, T. Bunch, 2007, Journal of liposome research.

Impact of proximal and distal pocket site-directed mutations on the ferric/ferrous heme redox potential of yeast cytochrome c peroxidase

D. Goodin, G. Jensen, 2011, Theoretical chemistry accounts.

Energetics of Cation Radical Formation at the Proximal Active Site Tryptophan of Cytochrome c Peroxidase and Ascorbate Peroxidase

A. Warshel, D. Goodin, G. Jensen, 1998 .

The axial ligands of heme in cytochromes: a near-infrared magnetic circular dichroism study of yeast cytochromes c, c1, and b and spinach cytochrome f.

P. Stephens, F. Devlin, G. Jensen, 1989, Biochemistry.

trans-1,2-Dicyano-cyclopropane and other cyano-cyclopropane derivatives

J. Gale, G. Jensen, K. Jalkanen, 2008 .

Site-directed mutagenesis of Azotobacter vinelandii ferredoxin I: [Fe-S] cluster-driven protein rearrangement

P. Stephens, G. Jensen, C. Stout, 1989 .

Protein control of iron-sulfur cluster redox potentials.

A. Warshel, P. Stephens, G. Jensen, 1992, The Journal of biological chemistry.

New liposomal formulations of cisplatin with improved therapeutic index

G. Jensen, I. Fichtner, C. Nowak, 2004 .